Healthcare and life science consultancy Lexica has appointed Michèle Wheeler as director of international health and life sciences.
HBSUK: Garry McCord and Mark Fountain
HBSUK, a provider of clinical insourcing to the NHS, has appointed Garry McCord as chief executive.
HBSUK was established in 2012 by healthcare professional and entrepreneur Mark Fountain, who makes way for McCord and becomes executive chair.
McCord previously worked for Servelec in numerous senior positions including chief product officer, chief operating officer and divisional chief executive.
Fountain said: “Data suggests that the current number of patients on a surgical wait list for treatment is around 7.2 million. HBSUK has successfully helped with waiting list reductions by doing insourcing on the weekends and evenings and also transferring increasing numbers of patients to digital pathways giving them more control over their own health. The future is ‘blended pathways’, allowing patients to seamlessly move between digital and physical services. HBSUK are the only current provider able to offer this end-to-end service or provide a product – Virtual Lucy – that allows healthcare providers to do this themselves.”
Executive search firm Carter Schwartz advised on the appointment.
Latest Executive Moves
TMC Pharma Services, a global product development and clinical research organisation has appointed Simon Estcourt as chief executive.
PharmaHealthcare Homes has appointed Martin Hill as operations director of its Manorcourt Homecare and Live-in care services.
Social care